« Back
Home /
CHRM4 Blocking Peptide (C-Term)

CHRM4 Blocking Peptide (C-Term)

Item no.	ABC-BP21733b
Manufacturer	Abcepta
Amount	500 ug
Category	Peptides & Proteins Cardiovascular Research Hypertension Peptides
Type	Peptides
Format	Lyophilized
Specific against	other
Citations	Bonner T.I.,et al.Science 237:527-532(1987). Bonner T.I.,et al.Neuron 1:403-410(1988). Peralta E.G.,et al.EMBO J. 6:3923-3929(1987). Puhl H.L. III,et al.Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases. Mural R.J.,et al.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	Muscarinic acetylcholine receptor M4,CHRM4
Similar products	CHRM4, Muscarinic acetylcholine receptor M4
Available
Manufacturer - Category	Peptides; Blocking Peptides
Manufacturer - Targets	The synthetic peptide sequence is selected from aa 221-236 of HUMAN CHRM4
Bio Background	The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is inhibition of adenylate cyclase.
Gene Name	CHRM4
Subtitle	Synthetic peptide
Formulation	Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

ABC-BP21733b-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 500 ug

available

Delivery expected until 11/6/2025

Express Delivery: Save 14 days

Compare

Add to wishlist

Get an offer